GENMAB A/S (GMAB) Form 6-K — Sep 29, 2026
Genmab A/S filed a 6-K disclosing the terms of its employee warrant schemes and a summary of all warrant grants issued through September 24, 2026 under board authorizations from general meetings dating back to 2017. The most recent grant, made on September 24, 2026, covers 13,331 ordinary shares with a nominal value of DKK 1 at an exercise price of DKK 2,268.00. Warrants vest after three years, expire seven years after issuance, and are personal and non-transferable except in limited circumstances such as transfer to a wholly-owned company of the holder.
Key figures
- Vesting years
- 3
- Latest grant date
- 2026-09-24
- Latest grant shares
- 13331
- Warrant expiry years
- 7
- Nominal share value dkk
- 1
- Latest grant exercise price dkk
- 2,268.00
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.